BeOne Medicines Ltd.
$297.49
$0.35(0.12%)
BeOne Medicines Ltd.
ONC
$297.49
$0.35(0.12%)
BeOne Medicines Ltd.
ONC
NASDAQ
$297.49
$0.35(0.12%)
Chart
Upcoming Earnings
Next report date
May 6, 2026
Report period
Q2 2026
EPS Estimate
$0.81
Revenue Estimate
$1.44B
Key stats
52-Week Range$297.49
$218.31
$385.22
Market capitalization
$31.79BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
172.00Basic EPS (TTM)
$23.24Net income (TTM)
$286.93MRevenue (TTM)
$5.34BAvg. volume
229.16KBeta (1Y)
0.50Employees
11.00KMarket capitalization
$31.79BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
172.00Basic EPS (TTM)
$23.24Net income (TTM)
$286.93MRevenue (TTM)
$5.34BAvg. volume
229.16KBeta (1Y)
0.50Employees
11.00KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout BeOne Medicines Ltd.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
John V. Oyler
Website
beonemedicines.comHeadquarters
, ,
IPO Date
2016-02-02
Identifiers
ISIN
US07725L1026Description
BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and...
Related Stocks
$74.45
1D:
1.3%
1Y:
-23.5%
CH0432492467Healthcare
Mkt Cap
$36.29B
P/E Ratio TTM
37.0
Revenue TTM
$10.40B
Beta
0.74
Earnings TTM
$980.00M
Dividend Yield TTM
0.45%
$117.53
1D:
4.8%
1Y:
8.5%
US00846U1016Healthcare
Mkt Cap
$33.21B
P/E Ratio TTM
25.1
Revenue TTM
$7.07B
Beta
1.30
Earnings TTM
$1.29B
Dividend Yield TTM
0.66%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate